Loading financial data...

AXIM BIOTECHNOLOGIES, INC. (AXIM) SEC Filings | Global Financial Data

AXIM BIOTECHNOLOGIES, INC.

AXIMSEC EDGAR

Pharmaceutical Preparations(NV)CIK: 1514946

15-12G

AXIM BIOTECHNOLOGIES, INC. FORM 15-12G

Filed: Dec 6, 2024

View on SEC

NT 10-Q

AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q

Filed: Nov 13, 2024 | Report: Sep 30, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Oct 15, 2024 | Report: Jan 30, 2024

View on SEC

8-K

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: Oct 15, 2024 | Report: Oct 9, 2024

View on SEC

10-Q

FORM 10-Q

Filed: Aug 19, 2024 | Report: Jun 30, 2024

View on SEC

NT 10-Q

AXIM BIOTECHNOLOGIES FORM 12B-25

Filed: Aug 13, 2024 | Report: Jun 30, 2024

View on SEC

10-Q/A

FORM 10-Q/A

Filed: May 22, 2024 | Report: Mar 31, 2024

View on SEC

10-Q

FORM 10-Q

Filed: May 20, 2024 | Report: Mar 31, 2024

View on SEC

NT 10-Q

AXIM BIOTECHNOLOGIES FORM 12B-25

Filed: May 15, 2024 | Report: Mar 31, 2024

View on SEC

10-K

FORM 10-K

Filed: Apr 16, 2024 | Report: Dec 31, 2023

View on SEC

NT 10-K

AXIM BIOTECHNOLOGIES, INC. - NT 10K

Filed: Apr 1, 2024 | Report: Dec 31, 2023

View on SEC

8-K

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: Mar 21, 2024 | Report: Mar 15, 2024

View on SEC

4/A

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

PRIMARY DOCUMENT

Filed: Mar 19, 2024 | Report: Mar 15, 2024

View on SEC

8-K

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: Feb 13, 2024 | Report: Feb 7, 2024

View on SEC

8-K

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: Dec 28, 2023 | Report: Dec 26, 2023

View on SEC

10-Q

FORM 10-Q

Filed: Nov 20, 2023 | Report: Sep 30, 2023

View on SEC

NT 10-Q

AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q

Filed: Nov 14, 2023 | Report: Sep 30, 2023

View on SEC

DEF 14C

AXIM BIOTECHNOLOGIES, INC. - DEF14C

Filed: Sep 21, 2023 | Report: Sep 21, 2023

View on SEC

PRE 14C

SCHEDULE 14C INFORMATION

Filed: Aug 31, 2023 | Report: Aug 30, 2023

View on SEC

10-Q

AXIM BIOTECHNOLOGIES FORM 10-Q

Filed: Aug 21, 2023 | Report: Jun 30, 2023

View on SEC

NT 10-Q

AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q

Filed: Aug 14, 2023 | Report: Jun 30, 2023

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: Jun 2, 2023 | Report: Jun 1, 2023

View on SEC

8-K

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: May 30, 2023 | Report: May 23, 2023

View on SEC

PRIMARY DOCUMENT

Filed: May 30, 2023 | Report: May 23, 2023

View on SEC

8-K

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: May 25, 2023 | Report: May 23, 2023

View on SEC

10-Q

FORM 10-Q

Filed: May 22, 2023 | Report: Mar 31, 2023

View on SEC

NT 10-Q

AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q

Filed: May 15, 2023 | Report: Mar 31, 2023

View on SEC

10-K

FORM 10-K

Filed: Apr 17, 2023 | Report: Dec 31, 2022

View on SEC

NT 10-K

AXIM BIOTECHNOLOGIES, INC. - NT 10K

Filed: Mar 31, 2023 | Report: Dec 31, 2022

View on SEC

8-K

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filed: Jan 27, 2023 | Report: Jan 23, 2023

View on SEC

10-Q/A

FORM 10-Q/A

Filed: Nov 15, 2022 | Report: Sep 30, 2022

View on SEC

10-Q

FORM 10-Q

Filed: Nov 14, 2022 | Report: Sep 30, 2022

Filed: Sep 23, 2022 | Report: Sep 23, 2022

View on SEC

PRIMARY DOCUMENT

Filed: Sep 23, 2022 | Report: Sep 23, 2022

View on SEC

PRIMARY DOCUMENT

Filed: Sep 23, 2022 | Report: Sep 23, 2022

View on SEC

PRIMARY DOCUMENT

Filed: Sep 23, 2022 | Report: Dec 10, 2020

View on SEC

PRIMARY DOCUMENT

Filed: Sep 23, 2022 | Report: Sep 23, 2022

View on SEC

PRIMARY DOCUMENT

Filed: Sep 23, 2022 | Report: May 13, 2020

View on SEC

Build with this data

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)

Get API Key (Free)